These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 29221826)

  • 1. Trends of invasive pneumococcal disease and its serotypes in the Autonomous Community of Madrid.
    Latasa Zamalloa P; Sanz Moreno JC; Ordobás Gavín M; Barranco Ordoñez MD; Insúa Marisquerena E; Gil de Miguel Á; Fernández Chávez AC; García-Comas L
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Dec; 36(10):612-620. PubMed ID: 29221826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.
    Balsells E; Guillot L; Nair H; Kyaw MH
    PLoS One; 2017; 12(5):e0177113. PubMed ID: 28486544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study.
    Bertran M; D'Aeth JC; Abdullahi F; Eletu S; Andrews NJ; Ramsay ME; Litt DJ; Ladhani SN
    Lancet Infect Dis; 2024 May; 24(5):546-556. PubMed ID: 38310905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive Pneumococcal Disease After 2 Decades of Pneumococcal Conjugate Vaccine Use.
    Yildirim I; Lapidot R; Shaik-Dasthagirisaheb YB; Hinderstein S; Lee H; Klevens M; Grant L; Arguedas Mohs AG; Cane A; Madoff L; Johnson H; Ivanof C; Burns M; Pelton S
    Pediatrics; 2024 Jan; 153(1):. PubMed ID: 38087952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study.
    Vadlamudi NK; Patrick DM; Hoang L; Sadarangani M; Marra F
    PLoS One; 2020; 15(9):e0239848. PubMed ID: 32997698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term surveillance of invasive pneumococcal disease: The impact of 10-valent pneumococcal conjugate vaccine in the metropolitan region of Salvador, Brazil.
    Reis JN; Azevedo J; de Oliveira AML; Menezes APO; Pedrosa M; Dos Santos MS; Ribeiro LC; Freitas HF; Gouveia EL; Teles MB; Carvalho MDG; Reis MG; Nascimento-Carvalho C; Verani JR
    Vaccine; 2024 Jan; 42(3):591-597. PubMed ID: 38184393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.
    Bardach A; Ruvinsky S; Palermo MC; Alconada T; Sandoval MM; Brizuela ME; Wierzbicki ER; Cantos J; Gagetti P; Ciapponi A
    PLoS One; 2024; 19(6):e0304978. PubMed ID: 38935748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of childhood pneumococcal vaccination and beta-lactam antibiotic use on the incidence of invasive pneumococcal disease in the adult population.
    Chávez AF; Comas LG; Moreno JCS; Moreno RC; de Provens OCP; Andrés JMA
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1529-1538. PubMed ID: 33641040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008.
    Moodley K; Coovadia YM; Cohen C; Meiring S; Lengana S; De Gouveia L; von Mollendorf C; Crowther-Gibson P; Quan V; Eley B; Reubenson G; Nana T; von Gottberg A
    Pediatr Infect Dis J; 2019 Apr; 38(4):424-430. PubMed ID: 30882740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013.
    von Mollendorf C; Cohen C; Tempia S; Meiring S; de Gouveia L; Quan V; Lengana S; Karstaedt A; Dawood H; Seetharam S; Lekalakala R; Madhi SA; Klugman KP; von Gottberg A;
    Emerg Infect Dis; 2016 Feb; 22(2):261-70. PubMed ID: 26812214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable Incidence of Invasive Pneumococcal Disease in Children in Northern France From 2014 Through 2018.
    Coronas E; Martinot A; Varon E; Wallet F; Dubos F;
    Pediatr Infect Dis J; 2021 Jul; 40(7):688-693. PubMed ID: 34097661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of invasive pneumococcal disease in Spain exploring the impact of the COVID-19 pandemic (2019-2023).
    Pérez-García C; Sempere J; de Miguel S; Hita S; Úbeda A; Vidal EJ; Llorente J; Limia A; de Miguel AG; Sanz JC; Martinón-Torres F; Ardanuy C; Domenech M; Yuste J
    J Infect; 2024 Aug; 89(2):106204. PubMed ID: 38906265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Invasive Pneumococcal Disease, North East England, UK.
    Houseman C; Hughes GJ; Chapman KE; Wilson D; Gorton R
    Emerg Infect Dis; 2017 Jan; 23(1):122-126. PubMed ID: 27983490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Streptococcus pneumoniae serotypes 8 and 22F causing invasive pneumococcal disease in the Czech Republic in 2014-2020: whole genome sequencing (WGS) analysis].
    Kozáková J; Vohrnová S; Honskus M; Křížová P
    Epidemiol Mikrobiol Imunol; 2024; 73(2):84-97. PubMed ID: 39060099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of previous macrolide use on invasive pneumococcal disease due to erythromycin-resistant serotypes in adults over 59 years of age.
    Chávez ACF; Comas LG; Espinosa LM; Lobo JY; de Provens OCP; Andrés JMA
    Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):227-234. PubMed ID: 34718890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2.
    Williams PCM; Howard-Jones A; Butters C; Koirala A; Britton PN; Duguid R; Wijeratne P; Johnson N; Jayasinghe S
    Pediatr Infect Dis J; 2023 Sep; 42(9):e341-e342. PubMed ID: 37200512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, Spain.
    González-Peris S; Campins M; García-García JJ; Díaz-Conradi Á; Domínguez Á; Ciruela P; de Sevilla MF; Hernández S; Muñoz-Almagro C; Izquierdo C; Codina G; Uriona S; Esteva C; Solé-Ribalta A; Soldevila N; Planes AM; Martínez-Osorio J; Salleras L; Moraga-Llop F;
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Oct; ():. PubMed ID: 33131931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological and molecular characterization of temperature- and CO
    Kobayashi J; Ohkusu M; Matsumoto T; Kubota N; Ishiwada N
    Microbiol Spectr; 2023 Dec; 11(6):e0216523. PubMed ID: 37823633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.
    Crowther-Gibson P; Cohen C; Klugman KP; de Gouveia L; von Gottberg A;
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5088-95. PubMed ID: 22802256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old.
    Buades J; Losada I; González-Moreno J; Peñaranda M; Vilaplana L; Roda N; Rey A; Rodriguez A; Garau M; de Gopegui ER; Serra A; Saurina J; Payeras A
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33513726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.